Navigation Links
Variable gene expression in zebrafish
Date:4/28/2014

This news release is available in German.

Early embryonic development of vertebrates is controlled by the genes and their "grammar". Decoding this grammar might help understand the formation of abnormalities or cancer or develop new medical drugs. For the first time, it is now found by a study that various mechanisms of transcribing DNA into RNA exist during gene expression in the different development phases of zebrafish. This study is presented by KIT researchers in the journal "Nature".

After several genomes have been sequenced and human genetic material has been decoded, many questions regarding the structure and function of genetic information still remain unanswered. On the DNA (deoxyribonucleic acid), the carrier of genetic information, scientists search for the grammar regulating gene expression, for instance. The result of this gene expression is the RNA (ribonucleic acid) that converts genetic information into proteins. A major pro-cess of gene expression is transcription, by which RNA is synthe-sized according to a DNA template. However, it is still unknown where exactly transcription starts and which regularly recurring DNA segments, DNA modifications or structural modifications of the DNA are required to determine the start of transcription. Complete understanding of transcription regulation might allow for specific interference with these mechanisms and the development of new medical drugs against diseases.

An international team of scientists, including Uwe Strhle, Head of the Institute of Toxicology and Genetics (ITG) of KIT, and his staff members Dr. Olivier Amant and Dr. Marco Ferg, studied the pro-cesses associated with the start of transcription in zebrafish in more detail. The ITG runs the European Zebrafish Resource Center (EZRC), a ce
'/>"/>

Contact: Monika Landgraf
presse@kit.edu
49-721-608-47414
Karlsruher Institut fr Technologie (KIT)
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. Price for hip replacement highly variable, hard to obtain
2. PCa markers improve predictive performance of existing clinical variables
3. Chicago Digital Printer Introduces Variable-Data Printing for Bulk iPhone Case Orders
4. Variable Valve Timing & Start-Stop Systems Market is Estimated to Grow at Highest CAGR of 16.43% from 2013 to 2018 – New Report by MarketsandMarkets
5. Variable Valve Timing Market and Start-Stop Systems is poised to grow up to 88.8 Million units and $9.8 Billion by 2018 - New Report by MarketsandMarkets
6. Changes in gene expression may help explain high blood pressure in pregnancy
7. Control of gene expression: Histone occupancy in your genome
8. Overexpression of proteins 14-3-3 related to chemotherapy resistance
9. Gene expression test identifies low-risk thyroid nodules
10. Gene expression improves the definition of a breast cancer subtype
11. Synthetic circuit allows dialing gene expression up or down in human cells
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Variable gene expression in zebrafish
(Date:7/30/2014)... 2014 Everyone knows that the internet is ... Whether people are looking for something to buy, trying to ... the internet is pretty much always going to be the ... Lauderdale Florida is so happy to announce the launch of ... into the modern age. Whether a person wants to know ...
(Date:7/30/2014)... 2014 “North America Contrast Media Injectors ... the North America Contrast Media Injectors market. The report ... (in units) and average price data (in US dollars), ...     Interventional Cardiology/Angio Injectors and MRI Injectors ... a substance used to enhance the contrast of structures ...
(Date:7/30/2014)... Association for Vedic Studies (WAVES) conference is coming to ... July 31 through Sunday, August 3. To watch the ... is the first time such a large and diverse ... campus to explore the relevance of ancient Vedic knowledge ... higher states of consciousness, and reflections on the various ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... have recently joined the Board of Directors of ... provides guidance for the Association, which has a ... in healthcare delivery through telecommunications and information technology. ... members of the Association, possess extraordinary expertise and ...
(Date:7/30/2014)... global digital pathology market was valued at an estimated $250.2 ... CAGR of 11.8%, to reach an estimated $437 million by ... is expected to continue to rise in the coming years ... enable pathologists to be efficient and this leads to improved ... market was valued at $128.9 million and accounted for the ...
Breaking Medicine News(10 mins):Health News:Sierra Dental Releases New Website For Fort Lauderdale Residents 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5
... decided to launch a ban on sale of Colas and junk ... and junk food may be out of school canteens across the ... are bad for children’s health. Hence, we want to ban the ... with Union Human Resource Development Ministry on the legal aspects of ...
... cancer is available in Singapore for those between the ... ,The Health Sciences Authority (HSA) gave its approval ... similar vaccine, Cervarix, from competitor GlaxoSmithKline, is awaiting approval ... health breakthrough, said Tay Eng Hseon, a doctor at ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... donated $30 million to University Hospitals (UH), a major ... turned his graduate thesis into a global automotive business ... himself, his wife Usha and their family, in support ... 2010. ,In recognition of the Ahuja family's ...
... treatment to remove lead from the body -- can significantly ... a// Cornell study of young rats finds. ,However, ... of autistic children, the researchers say that when rats with ... chemical, they showed declines in their learning and behavior that ...
... on women in their 70's to observe the relationship between ... followed nearly 12,000 women in// their 70’s over a 6 ... for 3-6 days/week, depending on alcoholic content) may lead to ... ,This study was published in Journal of the American ...
Cached Medicine News:Health News:Indian American Donates $30 Mn to Healthcare System 2Health News:Pros and Cons of Therapy for Lead Exposure 2
(Date:7/30/2014)... DIEGO , July 30, 2014   ... biotech company that designs and develops novel diagnostics ... of cancer, announced today the completion of a ... financing included new investors RusnanoMedInvest (RMI) and Arcus ... and Pfizer Venture Investments, as well as undisclosed ...
(Date:7/30/2014)... , 30. Juli 2014 ... ein führender Anbieter im Bereich Atemtherapie- und ... des Landgerichts München in Deutschland anfechten werden. ... bestimmten Masken ein Patent von ResMed verletze. ... in wichtigen Ländern gegen verschiedene Patente von ...
(Date:7/29/2014)... Amgen (NASDAQ: AMGN ) today ... Key results include: , Total revenues increased 11 ... growth driven by strong performance across the portfolio, particularly ... ® (denosumab) and XGEVA ® (denosumab). ... by higher revenues and a significant increase in the ...
Breaking Medicine Technology:Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25
... SUNNYVALE, Calif., Dec. 28, 2010 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its president and chief executive officer, ... 29th Annual J.P. Morgan Healthcare Conference in San Francisco on ... A live webcast of the presentation will be ...
... Medical Group Inc. (Nasdaq: WWIN ), ("Winner ... and non-woven fabric made from 100% natural PurCotton® products ... was recently held by Winner Medical and Cotton Incorporated ... in a high footprint shopping mall in Shanghai. ...
Cached Medicine Technology:Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference 2Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 2Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 3Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 4
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Series I Small Joint Arthroscopy Hand Instruments feature small yet durable instruments specifically designed for small joint arthroscopy. They are available in a variety of low profile styles: strai...
Low-profile, hand-held instrument....
Medicine Products: